Cancer Treatments and mRNA COVID Vaccines
Cancer patients who received an mRNA COVID vaccine within a few months of their immunotherapy showed improved survival rates, according to health records.
Research published on October 22 in Nature found that lung cancer patients who got the vaccine before immunotherapy lived nearly twice as long as unvaccinated patients.
The correlation suggests that mRNA vaccines — even those not designed for cancer — could make tumors more sensitive to current therapies.
A similar observation was made in people with melanoma, says Elias Sayour, a pediatric oncologist at the University of Florida College of Medicine.
- Lung cancer patients who received the vaccine lived nearly twice as long as unvaccinated patients.
- mRNA vaccines may make tumors more sensitive to current therapies.
Hua Wang, a cancer vaccine researcher at the University of Illinois Urbana-Champaign, finds this discovery "exciting" and "definitely important".
Author's summary: Cancer treatments may be improved by mRNA COVID vaccines.
More News
- Girlbands Forever reminds us of the toxic pressure women faced in the 2000s - and the progress still to be made
- From Reimagining Capitalism to Reweaving Ourselves: Leadership for a Sustainable and Caring Future in a World on Fire — Harvard ALI Social Impact Review
- Mega Millions jackpot reaches $800 million
- Iran Unveils Christian-Themed Metro Station Amid Religious Persecution Controversy
- Combining Ligand- and Structure-Based Methods for More Effective Virtual Screening
- Fall Back, But Don’t Fall Off —How To Keep Daylight Saving Time From Wrecking Your Relationship